Drug intelligence / Profile preview

ogerin

Development stage
Preclinical
Lead developer
University of North Carolina at Chapel Hill
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

Ogerin is a potent and selective small-molecule allosteric agonist of the G protein-coupled receptor 68 (GPR68), also known as ovarian cancer G protein-coupled receptor 1 (OGR1). GPR68 is a proton-sensing receptor that is activated by extracellular acidity and is involved in various physiological processes, including pH homeostasis, inflammation, and bone metabolism. Ogerin was discovered through a yeast-based high-throughput screen of the pharmacologically dark G protein-coupled receptors. It has been utilized as a chemical probe to investigate the role of GPR68 in the central nervous system, where it has been shown to modulate fear conditioning and hippocampal-dependent learning in mice. Ogerin demonstrates high selectivity for GPR68 over other closely related proton-sensing receptors such as GPR4, GPR65, and GPR174.

Other names
5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amineGPR68 agonist 1GPR-68 agonist 1GPR 68 agonist 1
02

Targets

CDK2 (Cyclin-dependent kinase 2)

Beyond the preview

Go deeper on ogerin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ogerin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call